1. Maki DG, Ringer M, Alvarado CJ. 1991; Prospective randomised trial of povidone-iodine, alcohol, and chlorhexidine for prevention of infection associated with central venous and arterial catheters. Lancet. 338:339–43. DOI:
10.1016/0140-6736(91)90479-9. PMID:
1677698.
Article
2. Mimoz O, Lucet JC, Kerforne T, Pascal J, Souweine B, Goudet V, et al. 2015; Skin antisepsis with chlorhexidine-alcohol versus povidone iodine-alcohol, with and without skin scrubbing, for prevention of intravascular-catheter-related infection (CLEAN): an open-label, multicentre, randomised, controlled, two-by-two factorial trial. Lancet. 386:2069–77. DOI:
10.1016/S0140-6736(15)00244-5. PMID:
26388532.
Article
3. Darouiche RO, Wall MJ Jr, Itani KM, Otterson MF, Webb AL, Carrick MM, et al. 2010; Chlorhexidine-alcohol versus povidone-iodine for surgical-site antisepsis. N Engl J Med. 362:18–26. DOI:
10.1056/NEJMoa0810988. PMID:
20054046.
Article
4. Climo MW, Yokoe DS, Warren DK, Perl TM, Bolon M, Herwaldt LA, et al. 2013; Effect of daily chlorhexidine bathing on hospital-acquired infection. N Engl J Med. 368:533–42. Erratum in: N Engl J Med 2013;368: 2341. DOI:
10.1056/NEJMoa1113849. PMID:
23388005. PMCID:
PMC5703051.
Article
5. Huang SS, Septimus E, Kleinman K, Moody J, Hickok J, Avery TR, et al. 2013; ; CDC Prevention Epicenters Program; AHRQ DECIDE Network and Healthcare-Associated Infections Program. Targeted versus universal decolonization to prevent ICU infection. N Engl J Med. 368:2255–65. Erratum in: N Engl J Med 2014;370:886.
Article
6. Milstone AM, Elward A, Song X, Zerr DM, Orscheln R, Speck K, et al. 2013; ; Pediatric SCRUB Trial Study Group. Daily chlorhexidine bathing to reduce bacteraemia in critically ill children: a multicentre, cluster-randomised, crossover trial. Lancet. 381:1099–106. DOI:
10.1016/S0140-6736(12)61687-0.
7. Rhee Y, Palmer LJ, Okamoto K, Gemunden S, Hammouda K, Kemble SK, et al. 2018; ; Centers for Disease Control and Prevention Epicenter Program. Differential effects of chlorhexidine skin cleansing methods on residual chlorhexidine skin concentrations and bacterial recovery. Infect Control Hosp Epidemiol. 39:405–11. DOI:
10.1017/ice.2017.312. PMID:
29493475. PMCID:
PMC8381229.
8. Huang SS, Septimus E, Kleinman K, Moody J, Hickok J, Heim L, et al. 2019; ; ABATE Infection trial team. Chlorhexidine versus routine bathing to prevent multidrug-resistant organisms and all-cause bloodstream infections in general medical and surgical units (ABATE Infection trial): a cluster-randomised trial. Lancet. 393:1205–15. Erratum in: Lancet 2019;393:1204. Erratum in: Lancet 2019; 394:470. DOI:
10.1016/S0140-6736(18)32593-5.
9. Huang SS, Singh R, McKinnell JA, Park S, Gombosev A, Eells SJ, et al. 2019; ; Project CLEAR Trial. Decolonization to reduce postdischarge infection risk among MRSA carriers. N Engl J Med. 380:638–50. DOI:
10.1056/NEJMoa1716771. PMID:
30763195. PMCID:
PMC6475519.
Article
10. Huang SS. 2019; Chlorhexidine-based decolonization to reduce healthcare-associated infections and multidrug-resistant organisms (MDROs): who, what, where, when, and why? J Hosp Infect. 103:235–43. DOI:
10.1016/j.jhin.2019.08.025. PMID:
31494130.
Article
11. Cho SY, Jeong JS, Kim EO, Kim YH. 2022; Effects of stepwise application of active surveillance culture, preemptive isolation, and chlorhexidine bed bath on the acquisition of methicillin-resistant
Staphylococcus aureus in children undergoing cardiac surgery in the pediatric intensive care unit. Korean J healthcare assoc Infect Control Prev. 27:35–42. DOI:
10.14192/kjicp.2022.27.1.35.
Article
12. Kim JS, Chung YK, Lee SS, Lee JA, Kim HS, Park EY, et al. 2016; Effect of daily chlorhexidine bathing on the acquisition of methicillin-resistant
Staphylococcus aureus in a medical intensive care unit with methicillin-resistant
S aureus endemicity. Am J Infect Control. 44:1520–5. DOI:
10.1016/j.ajic.2016.04.252. PMID:
27520786.
13. Suh JW, Kim NH, Lee MJ, Lee SE, Chun BC, Lee CK, et al. 2021; Real-world experience of how chlorhexidine bathing affects the acquisition and incidence of vancomycin-resistant enterococci (VRE) in a medical intensive care unit with VRE endemicity: a prospective interrupted time-series study. Antimicrob Resist Infect Control. 10:160. DOI:
10.1186/s13756-021-01030-6. PMID:
34758880. PMCID:
PMC8579179.
Article
14. Chung YK, Kim JS, Lee SS, Lee JA, Kim HS, Shin KS, et al. 2015; Effect of daily chlorhexidine bathing on acquisition of carbapenem-resistant
Acinetobacter baumannii (CRAB) in the medical intensive care unit with CRAB endemicity. Am J Infect Control. 43:1171–7. DOI:
10.1016/j.ajic.2015.07.001. PMID:
26297525.
15. Hong J, Jang OJ, Bak MH, Baek EH, Park KH, Hong SI, et al. 2018; Management of carbapenem-resistant
Acinetobacter baumannii epidemic in an intensive care unit using multifaceted intervention strategy. Korean J Intern Med. 33:1000–7. DOI:
10.3904/kjim.2016.323. PMID:
29172401. PMCID:
PMC6129627.
Article